Patient Support Hotline

Call (844) 244-1309

ZERO360 is a free, comprehensive patient support service to help patients and their families navigate insurance and financial obstacles to cover treatment and other critical needs associated with cancer.


Subscribe to our E-Newsletter

Stay up-to-date on the latest news about prostate cancer. Join our distribution list to receive periodic email updates and our monthly e-newsletter.

  • Patient Support (844) 244-1309
  • Search
  • e-News Signup Enews Signup
  • Run/Walk
  • Donate

- test

RT After Surgery Boosts Survival in Prostate Cancer With Lymph Node Involvement

The use of radiotherapy (RT) was associated with an overall survival benefit in patients with prostate cancer and lymph node... Read More

Test Can Predict Post-Op Radiotherapy Outcomes in Prostate Cancer

A new study showed that a 24-gene signature can predict outcomes following postoperative radiotherapy (RT) in patients with prostate adenocarcinoma... Read More

PSA Failure Associated With Mortality in Prostate Cancer Patients With Little Comorbidity

Prostate-specific antigen (PSA) failure in men with localized, intermediate-, or high-risk prostate cancer was associated with increased all-cause mortality in... Read More

Model Using PSA Test Can Help Predict Time to Prostate Cancer Relapse

A model based on a series of prostate-specific antigen (PSA) tests can predict the time to relapse in prostate cancer... Read More

1 2 3 4